Amalia M. Issa
Health Policy & Public Health
University of the Sciences
United States of America
Amalia M. Issa, PhD, MPH, FCPP is a pharmacologist and internationally renowned scientist in the field of personalized genomic medicine (precision medicine). Dr. Issa was one of the first scientists to develop a new and unique area of health outcomes and translational research focused on pharmacogenomics and personalized genomic medicine applications, and how they will be translated and integrated into health care delivery and health systems. She founded one of the first centers on Personalized Medicine and Targeted Therapeutics focused on the translation of personalized medicine into clinical practice and health policy in 2001. She joined the University of the Sciences in 2011, and brought this center with her. This Center accomplishes its mission through state-of-the-art research, training programs, consultation to government agencies on public policy initiatives, and national and international collaborations. Dr. Issa leads and collaborates with an interdisciplinary team of scientists nationally and internationally who are actively engaged in research aimed at translating personalized genomic medicine research from the laboratory bench to the bedside and to the clinic, community, and policy. Dr. Issa has numerous publications in the peer-reviewed scientific literature on pharmacogenomics and personalized medicine as well as in pharmacoepidemiology, neuropharmacology and drug safety. She has served or is serving as the principal investigator on a number of funded projects and is a reviewer for several scientific journals and national and international granting agencies. Dr. Issa serves on editorial boards and in leadership positions in several national and international professional associations and has received many awards and honors for her work, including the 2013 University of the Sciences’ Founder’s Day Faculty Award of Merit given to the faculty member who “represents the innovative and entrepreneurial spirit of the University Founders, and who has engaged in research that results in new developments or innovations” and is a Fellow of the College of Physicians of Philadelphia, the oldest national medical society.
Personalized medicine; pharmacogenomics; pharmaceutical outcomes research and policy; pharmacoepidemiology
Issa AM. 10 years of personalizing medicine: how the incorporation of genomic information is changing practice and policy. Personalized Medicine. 2015 Jan;12(1):1-3.
Issa AM, Chaudhari VS, Marchant GE. The value of multigene predictors of clinical outcome in breast cancer: an analysis of the evidence. Expert review of molecular diagnostics. 2015 Feb 1;15(2):277-86.
Patil D, Issa AM. Factors affecting the adoption and use of gene expression profiling by oncologists in clinical practice. Personalized Medicine. 2015 Jan 6;12(1):33-42.